DEVELOPMENT OF ANTITUMOR DENDRITIC CELL VACCINES WITH ALDH1A2 INHIBITORS TO OVERCOME IMMUNE SUPPRESSION. rjnmsr. 2026;4(3):659-676. doi:10.63075/1dpm7056